default author photo

C. Richter King

PATH's Malaria Vaccine Initiative

SCHOLARLY PAPERS

2

DOWNLOADS

76

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Identification of Highly Potent Transmission-Blocking Human Monoclonal Antibodies to Plasmodium falciparum Pfs230 in Naturally Exposed Individuals

Number of pages: 51 Posted: 08 Sep 2022
University of Toronto - Program in Molecular Medicine, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, TropIQ Health Sciences, TropIQ Health Sciences, Radboud University Nijmegen - Radboud Institute for Health Sciences, AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., PATH's Malaria Vaccine Initiative, Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, Stanford University - Department of Microbiology and Immunology, University of California, San Francisco (UCSF) - Department of Medicine, TropIQ Health Sciences, PATH's Malaria Vaccine Initiative, PATH's Malaria Vaccine Initiative, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology and Hospital for Sick Children Research Institute - Program in Molecular Medicine
Downloads 39 (1,196,171)

Abstract:

Loading...

Human monoclonal antibodies, malaria, natural infection, Plasmodium falciparum, transmission-blocking, Pfs230

2.

Highly Potent Naturally Acquired Human Monoclonal Antibodies Against Pfs48/45 Block Plasmodium falciparum Transmission to Mosquitoes

Number of pages: 57 Posted: 07 Sep 2022
Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, University of Toronto - Program in Molecular Medicine, TropIQ Health Sciences, TropIQ Health Sciences, TropIQ Health Sciences, AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., AbCellera Biologics Inc., Infectious Diseases Research Collaboration (Uganda), University of California, San Francisco (UCSF) - Department of Medicine, Stanford University - Department of Microbiology and Immunology, University of California, San Francisco (UCSF) - Department of Medicine, TropIQ Health Sciences, TropIQ Health Sciences, PATH's Malaria Vaccine Initiative, PATH's Malaria Vaccine Initiative, Radboud University Nijmegen - Department of Medical Microbiology, Hospital for Sick Children Research Institute - Program in Molecular Medicine and Radboud University Nijmegen - Department of Medical Microbiology
Downloads 37 (1,222,651)

Abstract:

Loading...

Malaria, Plasmodium falciparum, Human monoclonal antibodies, Crystallography, Pfs48/45, Transmission reducing activity, Transmission blocking vaccine